Award recordCONTRACT

OPTUM PHARMACY 801, INC.

PIID 36C25526N0168· VHA· 255-NETWORK CONTRACT OFFICE 15 (36C255)· Q517 · PHARMACY SERVICES· FY2026· $0 net obligations· UEI K5MHR9JB9ND5· AZ

Description

PHARMACY COMPOUNDING SERVICES -DE-OB EXCESS FUNDS IN SUPPORT OF A CLOSE OUT.

Base award description: PHARMACY COMPOUNDING SERVICES - THREE MONTHS EXTENSION

First action · last action
2026-02-12 · 2026-08-14
Transactions
2
First transaction's obligation
$150,000
Base + all options value (sum of deltas)
$0
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C25524A0009
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$150,000$0Base award · 2026-02-12 · this action $150,000 · running total $150,000Modification P00001 · 2026-08-14 · this action -$150,000 · running total $0
  • Base2026-02-12+$150,000= $150,000
  • Mod P000012026-08-14-$150,000= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-02-12+$150,000$150,000PHARMACY COMPOUNDING SERVICES - THREE MONTHS EXTENSION
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-08-14−$150,000$0PHARMACY COMPOUNDING SERVICES -DE-OB EXCESS FUNDS IN SUPPORT OF A CLOSE OUT.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI K5MHR9JB9ND5)

AwardOffice · PSC / listingNet obligationsFY
36C26126P0374261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$156,000FY2026
36C24226N0311242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$200,000FY2026
36C24226N0309242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$269,557FY2026
36C26026N0063260-NETWORK CONTRACT OFFICE 20 (36C260) · Q517 · PHARMACY SERVICES$557FY2026
36C24226N0127242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$20,584FY2026
36C24226N0167242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2026

Other recipients under Q517 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25526D0052OPTUM INFUSION SERVICES 308, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$0FY2026
36C25526N0089D & R PHARMACEUTICAL SERVICES, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$760,000FY2026
36C25526N0081PALISADE STRATEGIES, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$164,848FY2026
36C25526D0008PALISADE STRATEGIES, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$0FY2026
36C25525N0314PALISADE STRATEGIES, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$16,050FY2025

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25526N0168_3600_36C25524A0009_3600 · retrieved 2026-09-26.